Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

NORDIC MEDICARE A/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%   Bankruptcy risk   1.0% 1.3% 1.0% 0.6% 0.7% 0.6% 4.6% 4.6%   Credit score (0-100)   89 81 85 98 94 96 46 46   Credit rating   A A A AA AA AA BBB BBB   Credit limit (kDKK)   1,424.9 517.8 2,972.4 4,878.9 4,762.3 6,559.4 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   93,766 118,733 130,350 0 0 0 0 0   Gross profit   56,950 79,660 84,037 99,706 110,944 116,860 0.0 0.0   EBITDA   4,663 12,720 14,935 6,791 3,039 13,650 0.0 0.0   EBIT   3,271 11,136 13,396 4,184 354 9,922 0.0 0.0   Pre-tax profit (PTP)   3,114.6 11,055.5 13,269.0 4,004.6 235.4 9,809.9 0.0 0.0   Net earnings   2,426.7 8,613.3 10,316.1 3,075.2 175.0 7,634.3 0.0 0.0   Pre-tax profit without non-rec. items   3,115 11,056 13,269 4,005 235 9,810 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   9,263 7,810 10,595 13,694 14,097 15,460 0.0 0.0   Shareholders equity total   9,638 18,252 28,568 26,643 26,818 34,452 33,952 33,952   Interest-bearing liabilities   2,718 1,403 515 420 242 85.8 0.0 0.0   Balance sheet total (assets)   18,137 29,921 50,880 39,060 37,890 49,808 33,952 33,952   Net Debt   1,255 -7,190 -15,746 -1,581 -3,285 -10,455 -29,882 -29,882     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   93,766 118,733 130,350 0 0 0 0 0   Net sales growth   0.0% 26.6% 9.8% -100.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   56,950 79,660 84,037 99,706 110,944 116,860 0.0 0.0   Gross profit growth   41.9% 39.9% 5.5% 18.6% 11.3% 5.3% -100.0% 0.0%   Employees   78 94 102 132 145 128 0 0   Employee growth %   44.4% 20.5% 8.5% 29.4% 9.8% -11.7% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   18,137 29,921 50,880 39,060 37,890 49,808 33,952 33,952   Balance sheet change%   23.2% 65.0% 70.0% -23.2% -3.0% 31.5% -31.8% 0.0%   Added value   4,663.3 12,720.2 14,935.1 6,790.7 2,960.4 13,650.1 0.0 0.0   Added value %   5.0% 10.7% 11.5% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -1,135 -3,036 3,191 6,007 -3,217 -4,819 -15,460 0   Net sales trend   0.0 1.0 2.0 -1.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   5.0% 10.7% 11.5% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   3.5% 9.4% 10.3% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   5.7% 14.0% 15.9% 4.2% 0.3% 8.5% 0.0% 0.0%   Net Earnings %   2.6% 7.3% 7.9% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   4.1% 8.6% 9.1% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   3.3% 9.3% 10.2% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   19.9% 46.3% 33.3% 9.5% 0.9% 22.7% 0.0% 0.0%   ROI %   28.8% 69.6% 55.3% 15.2% 1.3% 31.5% 0.0% 0.0%   ROE %   28.8% 61.8% 44.1% 11.1% 0.7% 24.9% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   53.1% 61.0% 56.1% 68.2% 70.8% 69.2% 100.0% 100.0%   Relative indebtedness %   9.1% 9.8% 17.1% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   7.5% 2.6% 4.6% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   26.9% -56.5% -105.4% -23.3% -108.1% -76.6% 0.0% 0.0%   Gearing %   28.2% 7.7% 1.8% 1.6% 0.9% 0.2% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   5.3% 3.9% 21.1% 56.8% 35.8% 74.8% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.0 1.9 1.7 1.3 1.4 2.0 0.0 0.0   Current Ratio   1.0 1.9 1.7 1.3 1.4 2.0 0.0 0.0   Cash and cash equivalent   1,463.2 8,593.0 16,260.6 2,001.6 3,527.0 10,540.8 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   25.0 31.8 19.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   18.2 14.6 -92.7 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   8.6% 17.8% 28.3% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   186.9 9,957.3 14,895.6 3,782.9 4,049.5 13,943.1 0.0 0.0   Net working capital %   0.2% 8.4% 11.4% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   1,202 1,263 1,278 0 0 0 0 0   Added value / employee   60 135 146 51 20 107 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   60 135 146 51 21 107 0 0   EBIT / employee   42 118 131 32 2 78 0 0   Net earnings / employee   31 92 101 23 1 60 0 0